Pricing

Cyclo Therapeutics, Inc. (CYTH)

followers ·
Sector:
MATERIALS
Industry:
CHEMICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Scott Fine
Employees:
9
6714 NW 16TH STREET, SUITE B, GAINESVILLE, FL, 32653
386-418-8060
    Formally known as:
  • Cyclo Therapeutics Inc.
Stock Split History
DateRatio
2020-12-09 1:100
Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. In addition, it sells cyclodextrins and related products to pharmaceutical, nutritional, and other industries.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available